| 5308- | 5-HTP, | The Relationship Between Serotonin and 5-HTP |
| - | Review, | Nor, | NA |
| 5309- | 5-HTP, | Effects of Carbidopa on the Cerebral Accumulation of Exogenous L-5-Hydroxytryptophan in Mice |
| 5302- | 5-HTP, | Hippocampal ischaemia from accidental 5-Hydroxytryptophan (5-HTP) overdose case report |
| - | Case Report, | Nor, | NA |
| 5310- | 5-HTP, | 5-Hydroxytryptophan toxicity successfully treated by haemodialysis in a dog |
| - | Case Report, | Nor, | NA |
| 5311- | 5-HTP, | A case report of suspected serotonin syndrome following administration of fentanyl |
| 5303- | 5-HTP, | 5-HTP shows early promise for cognitive support and in seniors: Singapore study |
| - | Trial, | AD, | NA |
| 5298- | 5-HTP, | Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa |
| - | Human, | AD, | NA |
| 5297- | 5-HTP, | Targeting 5-HT Is a Potential Therapeutic Strategy for Neurodegenerative Diseases |
| - | in-vivo, | AD, | NA | - | in-vivo, | Park, | NA |
| 5296- | 5-HTP, | Serotonergic Regulation in Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 5295- | 5-HTP, | Safety of 5-hydroxy-L-tryptophan |
| - | in-vivo, | Nor, | NA |
| 5294- | 5-HTP, | Eosinophilia-myalgia syndrome case-associated contaminants in commercially available 5-hydroxytryptophan |
| - | in-vivo, | Nor, | NA |
| 5293- | 5-HTP, | The Role of Tryptophan Metabolism in Alzheimer’s Disease |
| - | in-vivo, | AD, | NA |
| 5292- | 5-HTP, | Past, present, and future of serotonin-targeting therapeutics for Alzheimer’s disease: Perspectives from DNA methylation |
| - | Review, | AD, | NA |
| 5291- | 5-HTP, | Kinetics of l-5-hydroxytryptophan in healthy subjects |
| - | in-vivo, | Nor, | NA |
| 5290- | 5-HTP, | Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers |
| - | in-vivo, | Nor, | NA |
| 5289- | 5-HTP, | 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology |
| - | Review, | AD, | NA | - | Review, | Arthritis, | NA |
| 5288- | 5-HTP, | The Impact of 5-Hydroxytryptophan Supplementation on Cognitive Function and Mood in Singapore Older Adults: A Randomized Controlled Trial |
| - | Trial, | AD, | NA |
| 5304- | 5-HTP, | Serotoninergic System in Dementia of the Alzheimer Type |
| - | Human, | AD, | NA |
| 5306- | 5-HTP, | Tryptophan-enriched diet or 5-hydroxytryptophan supplementation given in a randomized controlled trial impacts social cognition on a neural and behavioral level |
| - | Trial, | AD, | NA |
| 5301- | 5-HTP, | Eosinophilia-myalgia syndrome presenting with overlapping features of eosinophilic fasciitis and sarcoidal granulomas |
| - | Case Report, | NA, | NA |
| 5300- | 5-HTP, | The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice |
| - | Review, | Nor, | NA |
| 5299- | 5-HTP, | Serotonin Syndrome from 5-Hydroxytryptophan Supplement Ingestion in a 9-Month-Old Labrador Retriever |
| - | Case Report, | AD, | NA |
| 5307- | 5-HTP, | 5-Hydroxytryptophan toxicosis in dogs: 1989-1999 |
| - | Case Report, | Nor, | NA |
| 5305- | 5-HTP, | An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan Use |
| - | Review, | Nor, | NA |
| 3940- | 5HT, | Role of serotonin in Alzheimer's disease: a new therapeutic target? |
| - | Review, | AD, | NA |
| 3941- | 5HT, | dietMed, | VitB12, | FA, | VitC | Nutrition strategies that improve cognitive function |
| - | Review, | AD, | NA |
| 5312- | acet, | Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action |
| 5313- | acet, | Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition? |
| - | Review, | Nor, | NA |
| 5314- | acetaz, | Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment |
| - | Review, | Var, | NA |
| 1094- | ACNs, | Anthocyanidins inhibit epithelial-mesenchymal transition through a TGF-β/Smad2 signaling pathway in glioblastoma cells: Anthocyanidins inhibit TGF-β-mediated EMT. |
| - | in-vitro, | GBM, | U87MG |
| 1161- | ACNs, | immuno, | Bilberry anthocyanin extracts enhance anti-PD-L1 efficiency by modulating gut microbiota |
| - | in-vivo, | Colon, | MC38 |
| - | in-vivo, | AD, | NA |
| 3968- | ACNs, | Enhanced Neuronal Activation with Blueberry Supplementation in Mild Cognitive Impairment |
| - | Human, | AD, | NA |
| 3969- | ACNs, | Blueberry Supplementation in Midlife for Dementia Risk Reduction |
| - | Human, | AD, | NA |
| 3971- | ACNs, | Blueberry Supplementation Improves Memory in Older Adults |
| - | Human, | AD, | NA |
| 3972- | ACNs, | Recent Research on the Health Benefits of Blueberries and Their Anthocyanins |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3973- | ACNs, | Saskatoon and wild blueberries have higher anthocyanin contents than other Manitoba berries |
| - | Analysis, | AD, | NA |
| 3865- | ACNs, | Consumption of anthocyanin-rich cherry juice for 12 weeks improves memory and cognition in older adults with mild-to-moderate dementia |
| - | Human, | AD, | NA |
| 3864- | ACNs, | Anthocyanins Potentially Contribute to Defense against Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4163- | ACNs, | Flav, | Dietary levels of pure flavonoids improve spatial memory performance and increase hippocampal brain-derived neurotrophic factor |
| - | in-vivo, | AD, | NA |
| 1- | Aco, | Acoschimperoside P, 2'-acetate: a Hedgehog signaling inhibitory constituent from Vallaris glabra |
| - | in-vitro, | PC, | PANC1 | - | in-vitro, | Pca, | DU145 |
| 5459- | AF, | Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells |
| - | in-vitro, | Ovarian, | NA |
| 5466- | AF, | Auranofin Inhibition of Thioredoxin Reductase in a Preclinical Model of Small Cell Lung Cancer |
| - | in-vivo, | Lung, | NA |
| 5465- | AF, | The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression |
| - | in-vitro, | OS, | NA |
| 5464- | AF, | Inhibition of Thioredoxin-Reductase by Auranofin as a Pro-Oxidant Anticancer Strategy for Glioblastoma: In Vitro and In Vivo Studies |
| - | vitro+vivo, | GBM, | NA |
| 5463- | AF, | Will Auranofin Become a Golden New Treatment Against COVID-19? |
| - | Review, | Covid, | NA |
| 5462- | AF, | Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy |
| - | Review, | Var, | NA |
| 5461- | AF, | Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
| 5460- | AF, | Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species |
| - | vitro+vivo, | Var, | 4T1 |
| 5469- | AF, | Ligand supplementation restores the cancer therapy efficacy of the antirheumatic drug auranofin from serum inactivation |
| - | in-vitro, | CRC, | HCT116 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid